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cerevisiae were studied. The uptake of both drugs was very fast, linear with concentration and not dependent
on glucose, indicating entrance by diffusion and concentrating inside. Low (5.0 μM) to intermediate
concentrations (40 μM) of both drugs produced a glucose-dependent K+ efﬂux; higher ones also produced a
small inﬂux of protons, probably through a K+/H+ exchanger, resulting in a decrease of the internal pH of the
cells and the efﬂux of material absorbing at 260 nm and phosphate. The cell membrane was not
permeabilized. The K+ efﬂux with miconazole was dependent directly on the medium pH. This efﬂux results
in an increased membrane potential, responsible for an increased Ca2+ uptake and other effects. These effects
were not observed with two triazolic antifungals. A decrease of the Zeta (ζ) potential was observed at low
concentrations of miconazole. Although the main effect of these antifungals is the inhibition of ergosterol
synthesis, K+ efﬂux is an important additional effect to be considered in their therapeutic use. Under certain
conditions, the use of single mutants of several transporters involved in the movements of K+ allowed to
identify the participation of several antiporters in the efﬂux of the cation.lycine, adjusted to pH 8.0 with
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Several imidazolic compounds have been used as antifungals.
Their main action has been deﬁned as blockers of sterol biosynthesis
[1,2] and that of steroid hormones through the inhibition of P450
cytochromes [3–5]. Miconazole also has an oligomycin-like inhibitory
effect on the mitochondrial ATPase [6,7] and produces K+ efﬂux,
accompanied by an increased Ca2+ uptake [8]. Ketoconazole has been
identiﬁed as an inhibitor of the Ca2+-activated K+ current in the
pituitary gland [9], in erythrocytes [10,11], and in a Ca2+/H+
exchange in the vacuole of Trypanosoma bruceii [12], indicating its
interaction with cation transport systems. Resistance genes for these
compounds have been described [13,14].
Although the mode of action of these substances has been
extensively studied, as pointed out in [15], only ketoconazole uptake
has been studied in Candida albicans [16], but no reports were found
about miconazole, and few other effects have been studied. This work
reports results on the internalization of both drugs, as well as othereffects on the yeast Saccharomyces cerevisiae as a model fungus.
Ketoconazole and miconazole were selected among the most used
imidazolic antifungals; two other triazolic compounds, ﬂuconazole
and itraconazole, were also studied.
2. Material and methods
2.1. Yeast strains and culture conditions
A S. cerevisiaewild type strain was isolated as a single colony from
commercial yeast (La Azteca, S.A., Mexico).
FY833 was kindly donated by Dr. M. Ghislain through Dr. Mónica
Montero, University of Rio de Janeiro, Brazil [17]. All mutants were
constructed in FY833 strain, using the PCR-based deletion: Δnhx1 and
Δkha1 (this work).
The double mutant Δkha1–Δnha1 was generated from Δnha1
described in [18].
Δtrk1, Δtrk2, and Δtrk1–Δtrk2 were reported in [19].
W303-1A [20] and TOW (Δtok1) were kindly provided by Drs.
Lydie Maresova and Hana Sychrova, Academy of Sciences, Prague,
Czech Republic [21]. All strains used are described in Table 1.
Oligonucleotides used to construct deletion cassettes are listed in
Table 2. PCR-generated kha1::HIS3, nhx1::kanMX, disruption cassettes
were obtained using the oligonucleotide pairs F1/R1 KHA1, F1/R1
NHX1, respectively, and plasmids pFA6a-TRP1, pFA6a-kanMX6, and
pFA6a-His3MX6 as templates according to Longtine et al. [22]. These
deletion cassettes contain the speciﬁed auxotrophy markers (TRP1 or
HIS3) or the kanamycin-resistance marker ﬂanked by ca. 40 bp of
Table 1
Mutants used in this work.
Name Genotype Reference
FY833 MATa-his3-Δ200, ura3-52, leu2-Δ1,
lys2-Δ202, trp1-Δ63, GAL2+
Masuda et al. [17]
Δnha1 MATa-Δnha1::TRP1 Peña et al. [18]
Δtrk1 MATa-Δtrk1::KAN Peña et al. [18]
Δtrk2 MATa-Δtrk2::HIS3 Peña et al. [18]
Δtrk1–Δtrk2 MATa-Δtrk1::TRP1-Δtrk2::KAN Michel et al. [19]
W303-1A MATa-ade2-Δ1, can1-Δ100, his3-Δ11,15,
leu2-Δ3,112, trp1-Δ1 ura 3-Δ1::URA3
Wallis et al. [20]
TOW (Δtok1) MATa-tok1Δ::kanMX Maresova et al. [21]
Δkha1 MATa-Δkha1::HIS3 This work
Δkha1–Δnha1 MATa-Δkha1::HIS3-Δnha1::TRP1 This work
Δnhx1 MATa-Δnhx1::kanMX This work
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gene on each side, respectively. For KHA1 and KHA1–NHA1 deletions,
yeast transformants were selected on synthetic deﬁned media lacking
the appropriate amino acid; for NHX1 deletion, transformants were
selected in YPD media (1% yeast extract, 2% peptone, 2% glucose)
supplemented with G418 (300 μg mL−1). Yeast transformation was
performed using the lithium acetate method according to Gietz [23].
Deletions were conﬁrmed by PCR, using external oligonucleotides
for each gene, or an oligonucleotide located 5′ to the ORF of the gene
and an oligonucleotide located within the kanamycin or the
corresponding amino acid coding region.
La Azteca yeast was grown in 500 mL of YPD medium (1% yeast
extract, 2% bactopeptone, and 2% glucose). After 24 h of growth, the
cells (around 8 g) were collected by centrifugation, washed with
distilled water, and aerated in 250 mL of water for 16 to 18 h in an
orbital shaker at 30 °C. After starvation, cells were collected by
centrifugation, washed with water and suspended in water at a ratio
of 0.5 g per mL, and maintained on ice until use, during the same day.
FY833 and its mutants were grown as described for La Azteca, in YPD
medium, but supplemented with their amino acid requirements. For
Δtrk1, Δtrk2, and Δtrk1–Δtrk2 the medium was also supplemented
with 100 mM KCl and fasted in the absence of the salt. W303-1A and
TOW (Δtok1) were grown in YPD, but the mediumwas supplemented
with adenine (80 mg L−1) and uracil (30 mg L−1).
In experiments at different pH values, the cells (50 mg, wet
weight) were incubated in 10 mMMES-TEA, pH 6.0, or 10 mM bicine-
TEA, pH 8.0, or 10 mM HOMOPIPES-TEA, pH 4.0, 25 mM glucose, and
the indicated concentrations of ketoconazole or miconazole, in a ﬁnal
volume of 4.0 mL. Glucose or other additions are as indicated in
individual experiments.
2.2. Ketoconazole uptake and efﬂux of nucleotides
Ketoconazole uptake was determined from the concentration of
the drug remaining in the supernatant after incubation and
centrifugation of the cells, and this supernatant was also used to
measure the efﬂux of nucleotides (material absorbing at 260 nm); the
latter as an index of a possible membrane disruption by the drug. After
incubation for 10 min at 30 °C and centrifugation of the cells, 40 μL of
1 N NaOH was added to a 2.0 mL aliquot of the supernatant; this
addition was found to increase the extraction yields of ketoconazole
from the supernatants with dichloromethane (CH2Cl2), of whichTable 2
Gene sequences and oligonucleotides used in this study.
F1KHA1 5′-ATGGCAAACACTGTAGGAGGAATTCTGTCGGGTGTAAATCCGGATCCCCGGGTTAA
R1KHA1 5′-AAATTAAGAACAAAGAAAATTAAAAAATTTCTGCTGATACGAATTCGAGCTCGTTTAA
F1NHX1 5′-ATGCTATCCAAGGTATTGCTGAATATAGCTTTCAAGGTGCCGGATCCCCGGGTTAATTA
R1NHX1 5′-TCTAGTGGTTTTGGGAAGAGAAATCTGCAGGTGATTGCGTGAATTCGAGCTCGTTTAA
Underlined sequences correspond to the PCR primers used to amplify the transformation m3.0 mL was found sufﬁcient to extract the drug from the aqueous
phase. The extraction was achieved by stirring in a vortex and
centrifuging. The absorbance of the upper aqueous layer was
determined at 260 nm to measure nucleotide efﬂux. The absorbance
of the remaining lower layer of CH2Cl2 was measured at 288 nm and
compared with a standard curve of ketoconazole prepared by adding
the compound at different concentrations to 2.0 mL of 10 mM MES-
TEA buffer, pH 6.0, plus 20 mM NaOH and extracting with CH2Cl2 in
the same way as the samples. Extraction was necessary because,
although ketoconazole shows an absorbance peak at 288 nm, it also
shows a strong absorbance at 260 nm.
2.3. Miconazole uptake
Miconazole uptake was measured after incubation of the cells in a
similar way, but after centrifugation, 2.0 mL of the supernatant or an
adequate dilution in 10 mM MES-TEA buffer, pH 6.0, was mixed with
25 μM pentachlorophenol and 0.5 μM DiSC3(3). Fluorescence was
then measured at 540–590 nm, and the concentrations in the
supernatants were calculated by comparing against a standard
curve of miconazole prepared in the same way. This method was
developed from the fortuitous ﬁnding that miconazole, in the
presence of FCCP or pentachlorophenol, in micromolar concentra-
tions, produced a linearly increased ﬂuorescence of DiSC3(3) at 540–
590 nm, which was adequate to measure miconazole concentrations
of up to 25 μM.
2.4. Glucose-6-phosphate dehydrogenase
Glucose-6-phosphate dehydrogenase was measured by incubating
25 mg of cells in the presence of 5 μM NADP+ plus 5 μM glucose-6-
phosphate and following the reduction of the nucleotide by its
absorbance at 340 nm in the spectrophotometer. The assays were also
carried out in the same way with cell-free extracts prepared by
breaking the cells with glass beads for 1 min in a vortex and cooling
for 1 min, repeating the procedure 10 times, and then centrifuging at
1500 g in the SS34 rotor of a refrigerated Sorvall centrifuge during
10 min. Approximately 2 mg of protein was used for the assay.
2.5. Efﬂux of K+ and proton pumping
The efﬂux of K+ was measured by incubating for 10 min, at 30 °C,
50 mg of cells, wet weight, in a ﬁnal volume of 4.0 mL of the indicated
buffer (10 mM), 25 mM glucose, plus the drugs at the concentrations
indicated under each experiment. After incubation, the cells were
centrifuged, and the supernatant used to measure K+. The original
total K+ content of the cells was measured by boiling in a bath for
20 min a similar suspension of the cells in water and centrifuging. K+
was measured in the supernatant by ﬂame photometry.
The efﬂux of K+ and proton pumping were also measured with pH
and K+ selective electrodes, connected to a pHmeter and a computer.
The incubation medium contained 125 mg of cells, 2 mM MES-TEA,
pH 6.0, and 25 mM glucose in a ﬁnal volume of 10 mL, and incubation
was performed in a constant temperature chamber under continuous
stirring at 30 °C. The drugs were added after 3 min at the indicated
concentrations. In both cases, reference scales were obtained by the
addition of known concentrations of KCl or HCl to the medium in the
absence of cells.TTAA-3′
AC-3′
A-3′
AC-3′
odules according to Longtine et al. [22].
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The uptake of 86Rb+ was measured by adding 50 mg of cells to
1.0 mL, ﬁnal volume of 10 mM MES-TEA, pH 6.0, and 25 mM glucose
at room temperature (25 °C). After three minutes, 86RbCl was added
at concentrations of 1, 2, 5, and 10 mM. An aliquot of 100 μL was taken
and ﬁltered through a 0.25 μm nitrocellulose ﬁlter and washed twice
with 5.0 mL of 100 mM KCl. The ﬁlters were then dried and placed in
scintillation vials and counted in a Beckman scintillation counter.
2.7. Internal pH
Internal pHwasmeasured by the ﬂuorescence changes of pyranine
introduced to the cells by electroporation, as described before [24],
incubating under the conditions described for each experiment. The
cells (25 mg, wet weight) were incubated in 2.0 mL, ﬁnal volume, of
10 mM MES-TEA, pH 6.0, and 25 mM glucose. The ﬂuorescence
changes (460–520 nm) of the dye were measured in a spectroﬂuo-
rometer (SLM) under continuous magnetic stirring, in a cell
compartment thermostated at 30 °C. The internal pH was then
calculated from the ﬂuorescence changes with the corrections
described before [24].
2.8. Plasma membrane potential
The plasma membrane potential (PMP) difference was initially
estimated as described before [25], by following the ﬂuorescence
changes of DiSC3(3). The cells (25 mg) were added to the spectroﬂu-
orometer cell containing 10 mM MES-TEA buffer, 10 μM CCCP, 10 μM
BaCl2, and 0.25 μM cyanine, in a ﬁnal volume of 2.0 mL. When
indicated, either 25 mM glucose or 10 mM KCl was added. The
ﬂuorescence changes (540–590 nm) were followed against time in an
SLM spectroﬂuorometer equipped with a cell holder at 30 °C. In the
experiments with miconazole, CCCP was omitted since it produces by
itself an increased ﬂuorescence, as stated earlier. In order to obtain a
quantitative parameter, in another series of experiments, after
incubating the cells, the DiSC3(3) concentration remaining outside
was measured in the supernatant by its ﬂuorescence at the same
wavelengths in the presence of 1.0% sodium dodecylsulfate. The
internal concentration of cyanine was obtained from this value,
considering 0.37 mL g−1 wet weight as the internal water volume of
the cells [26]. The PMP value was then calculated from the ratio of the
internal/external concentrations of cyanine by means of the Nernst
equation.
2.9. Inorganic phosphate determination
The efﬂux of inorganic phosphate was determined in similar
experiments to those in which K+ efﬂuxwasmeasuredwith the ﬂame
photometer, but inorganic phosphate was measured in the superna-
tant obtained by centrifuging the cells after incubation without or
with the antifungals at different concentrations. The method of Fiske
and Subbarow was used [27].
2.10. Zeta (ζ) potential
This parameter was obtained from the velocity of cell displace-
ment under an electric ﬁeld, determined directly under the micro-
scope in a Zeta Meter ZM-75 cell electrophoremeter. The cells (25 mg,
wet weight) weremixedwith 15.0 mL of 10 mMHOMOPIPES-TEA, pH
4.0, or MES-TEA, pH 6.0, or Bicine-NaOH, pH 8.0, buffer, in the Z-meter
electrophoremeter, and after applying 102 V, the migration time for
500 μm was measured, and this was used to calculate the electro-
phoretic mobility as explained in [18].2.11. Effects on the viability of the cells
To explore this parameter, after incubating the cells in the
presence of variable concentrations of the antifungals, as described
to measure H+ and K+ ﬂuxes with a selective electrode, a known
number of cells were plated on YPD to observe the colony forming
units (CFU) as an index of the survival of the cells.
2.12. Oxygen consumption
Oxygen consumption by the cells was measured with a Clark
electrode connected to a polarization and measurement device
(Yellow Springs) connected to a computer. The medium (3.0 mL,
ﬁnal volume) contained 10 mM MES-TEA buffer, pH 6.0, 25 mM
glucose and 25 mg of cells. Different micromolar concentrations of
miconazole were already present during the experiment. After 250 s,
10 μM of CCCP was added. The experiments were conducted in a
closed chamber, under continuous stirring, at 30 °C.
Reagents were of the highest quality available, obtained from
Sigma Chemical Co. (St Louis, MO, USA), except for dichloromethane
obtained from Merck, and DiSC3(3) from Molecular Probes. Octylgua-
nidine was synthesized according to the procedure reported by
Phillips and Clarke [28] and recrystallized twice from water.
3. Results
3.1. The uptake of the antifungals
The procedure designed to measure the remaining drugs after
incubation with the cells produced reasonable results, except perhaps
for the lowest and highest concentrations of ketoconazole, whose
uptake was measured only up to 200 μM. As Fig. 1 shows, the uptake
was not saturable; it followed a practically linear behavior with the
concentration of the drugs, at all concentrations, approximately 75% of
the ketoconazole and 90% of the miconazole added were taken up by
the cells. Besides, the uptake did not depend on the presence of
glucose. In other experiments it was found that the uptake reached
similar values when measured by incubating the cells on ice and
centrifuging them immediately, or after incubating them at 30 °C for
10 min (not shown).
3.2. The antifungals produce an efﬂux of K+ and the entrance of protons
Following the effect of the antifungals with K+ and H+ selective
electrodes (Figs. 2 and 3), it was found that: a) at concentrations as
low as 5.0 μM an efﬂux of K+ could be observed with both drugs;
b) miconazole was more effective than ketoconazole; c) the effect
partially depended on the presence of glucose, more so for
miconazole; d) an increase of the pH of the medium was detected
with both antifungals starting at 20 to 40 μM, suggesting the entrance
of protons to the cells. This apparent inﬂux of H+ was much lower
than the efﬂux of K+. Incubation of the cells with various concentra-
tions of each antifungal induced a K+ efﬂux to the incubationmedium,
which increased with concentration and, at around 200 μM, it was
close to 100% (see also Fig. 7).
Two triazolic antifungals, ﬂuconazole and itraconazole were tested
and they did not produce the efﬂux of K+, even when added at 400 μM
(not shown). The efﬂux produced by octylguanidine, an organic cationic
molecule previously described to produce an efﬂuxof K+,was tested. As
found before [30], this compound produced some efﬂux of the cation,
but only at concentrations higher than 400 μM (not shown).
3.3. The antifungals do not produce permeabilization of the cells
A possible disruption of the cells was ﬁrst tested by analyzing
the efﬂux of nucleotides as the material absorbing at 260 nm after
Fig. 1. Uptake of ketoconazole (K) and miconazole (M) by commercial yeast cells
(La Azteca S.A., Mexico) at different concentrations in the presence or absence of
glucose (G). The cells were incubated for 10 min at 30 °C in the presence of the
antimycotic at the indicated concentrations. Aliquots were centrifuged, and the
remaining antifungals were measured in the supernatant as described under Material
and methods.
Fig. 2. Efﬂux of K+ from yeast produced by ketoconazole (A and B) or miconazole (C and D)
beginning of the tracings. After 3 min, the antifungals were added at the indicated microm
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methods). Fig. 4A shows that an efﬂux of this material occurred, but
with the highest concentrations of ketoconazole; in the presence of
glucose, it reached a maximum of 14% of the total material (measured
in the supernatant after boiling and centrifuging the cells). This efﬂux
was also higher with miconazole than with ketoconazole, and
partially glucose-dependent, except for the highest concentrations.
A small efﬂux, observed without the antifungals, also required the
presence of glucose (it was smaller in the absence of a substrate).
The efﬂux of inorganic phosphate was also measured, and the
experiments showed an increased efﬂux of this anion (Fig. 4B). At the
highest concentrations of the drugs, the efﬂux percentage of this
anion reached close to 80% of the total content of the cells, whereas
that of K+ was close to 100%. With ketoconazole, the efﬂux depended
on glucose at all concentrations, whereas with miconazole this
dependence was observed only at the lower concentrations.
The efﬂux of nucleotides and phosphate indicates a permeabiliza-
tion of the cells. Another way to explore the possible permeabilization
of the cells was measuring the activity of glucose-6-phosphate
dehydrogenase in intact cells incubated in the presence of various
concentrations of the antifungals. If the cells were permeabilized,
glucose-6-phosphate and NADP+ should enter the cells, and the
corresponding enzyme activity should be detected. In cell-free
extracts incubatedwith glucose-6-phosphate and NADP+, a reduction
of the nucleotide could be detected easily as an increase of absorbance
at 340 nm in the spectrophotometer. However, by incubating the cellsin the presence (A and C) or absence of glucose (B and D). Yeast cells were added at the
olar concentrations. K, ketoconazole; M, miconazole.
Fig. 3. Effects of ketoconazole (A and B) andmiconazole (C and D) in the presence (A and C) or absence of glucose (B and D) on the H+ concentration of the medium. The experiment
was carried out simultaneously to that of Fig. 2, but the changes were followed with a pH selective electrode. K, ketoconazole; M, miconazole.
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concentrations up to 400 μM, no reduction of the nucleotide was
observed (not shown). It was veriﬁed that none of the antifungals
inhibited the enzyme in cell-free extracts.Fig. 4. Efﬂux from yeast of material absorbing at 260 nm (A) or phosphate (B) produced by k
−G) or absence (M or K) of glucose. The material absorbing at 260 nm and the phosphate3.4. The antifungals do not inhibit the uptake of Rb+
Since after the initial efﬂux of K+ detected with the electrode,
particularly above 10 μM of the antifungals, no net reuptake of theetoconazole (K) or miconazole (M). Incubations were made in the presence (M−G or K
were measured in the supernatant as described under Material and methods.
Fig. 5. Effects of ketoconazole (A and B), or miconazole (C and D) on the internal pH of yeast cells measured by the ﬂuorescence changes of pyranine, in the presence (A and C) or
absence (B and D) of glucose. The internal pHwasmeasured by following the changes of ﬂuorescence at 460–520 nm, as described underMaterial andmethods. Numbers next to the
tracings indicate the micromolar concentrations of ketoconazole (K) or miconazole (M) added where indicated, as well as the addition of 25 mM KCl.
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of the uptake of the cation by the drugs. The uptake of 86Rb+ was
measured at concentrations of 1, 2, 5, and 10 mM of 86RbCl, against 0,
5, 10, 20, and 40 μM of each antifungal. No inhibition of the uptake
was observed (not shown).
3.5. The antifungals produce a K+/H+ exchange
The ﬁndings shown in Figs. 2 and 3 point out a possible efﬂux of K+
through two mechanisms; the main one, at low concentrations of the
antifungals, is the extrusion of the cation from the cells without any
change of themediumpH. However, at higher concentrations (40 μMor
higher), althoughat amuch lowerdegree, the additionof theantifungals
produced an inﬂux of protons, indicating a possible K+/H+ exchange.
Hence, we decided to follow the changes produced by both drugs on the
internal pH of the cells. In the absence of the drugs, glucose addition
resulted in an internal cellular alkalinization that can be further
increased by the addition of K+, because the cation abates the plasma
membrane potential difference (PMP) [24], which in turn accelerates
the H+-ATPase of the plasmamembrane [31]. At intermediate (50 μM)
or higher, butnot at lowconcentrations, bothdrugs produced adecrease
of the internal pH (Fig. 5A and C). The response of the internal pH to
further addition of K+ was slightly decreased; at the higher concentra-
tions, this alkalinization presented two phases, one of them very fast,and a second onemuch slower than that observed in the control cells or
those to which the drugs were added at low concentrations. Since the
efﬂux of K+ was glucose-dependent [29,30], similar experiments
were carried out measuring the effect of different concentrations of
the drugs on the changes of the internal pH in the absence of
substrate (Fig. 5B and D). The presence of the drugs produced a
smaller internal acidiﬁcation, starting at around 50 μM, but similarly
to K+ efﬂux, this wasmore clearly observed at higher concentrations.
Besides, further addition of K+ produced a similar biphasic
alkalinization, rapid at ﬁrst, as observed in the presence of glucose.
Miconazole, at equivalent concentrations (Fig. 5C and D) was more
active, both in the presence and absence of glucose, and the internal
acidiﬁcation of the cells was much faster. Ketoconazole at the higher
concentrations, in the absence of glucose (Fig. 5B), also produced a
decrease of the internal pH, which could be almost reversed by
further addition of KCl.
3.6. The efﬂux of K+ is electrogenic
Since the drugs at low concentrations produced an efﬂux of K+,
apparently not in an exchange for H+, it was tested whether the
phenomenon was electrogenic. For that purpose, the PMP difference
was estimated by following the ﬂuorescence changes of the cyanine
DiSC3(3) [25]. It had been reported that miconazole induces a
Fig. 6. Changes in the potential difference of the plasma membrane produced by ketoconazole (A and B) or miconazole (C and D), in the presence (A and C) or absence of glucose
(B and D). The changes were estimated by following the ﬂuorescence changes of the cyanine DiSC(3)3. Where indicated, 50 mM KCl was added under all experimental conditions.
Numbers next to the tracings indicate the micromolar concentration of ketoconazole or miconazole already present in the incubation.
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presence of glucose, ketoconazole (Fig. 6 A) and miconazole (Fig. 6C)
produced: a) an increase in both the rate of increase and maximal
values of ﬂuorescence, indicating a faster installation and higher PMP,
dependent on the concentration; b) in the absence of glucose (Fig. 6B
and D), the effects of both compounds weremuch smaller; c) in either
the presence or absence of glucose, miconazole was more active than
ketoconazole at comparable concentrations; d) when K+ was added,
it produced the expected decrease of the PMP [25], which was smaller
in the presence of the drugs, as compared with the control tracing.
Besides, as another indicator of the PMP, the effect of ketoconazole and
miconazole on the net uptake of DiSC3(3) was measured (see 3.10.3).
Furthermore, as another indicator of the increased PMP of the cells
by the drugs, we measured the uptake of 45Ca2+, and found that both
drugs at 100 μMproduced a remarkably increased uptake of about ﬁve
fold (not shown), in agreement with the report of Eilam et al. [8].
3.7. The K+ efﬂux depends on the pH of the medium
At the higher concentrations of the antifungals, results agreed with
a stimulation of a K+/H+ exchange. Because of this, another
experiment was carried out in which the efﬂux of K+ was determined
as a function of pH. In this experiment the cells were incubated with
orwithout glucose for 10 min at pH 4.0, 6.0, or 8.0; then, the cells werecentrifuged and K+ was measured in the supernatants with a ﬂame
photometer. Fig. 7 shows that the efﬂux produced by 100 μM
miconazole increased as the pH was lowered, in either the absence
or presence of glucose. With ketoconazole, at the same concentration,
dependence of the K+ efﬂux on the pH was different, being more or
less similar at pH 6.0 and 8.0, but much smaller at pH 4.0.
3.8. Miconazole reduces the negative Zeta potential of the cells
Amiodarone, another cationic amphipathic molecule, has been
shown to partially bind to yeast cells, increasing (to less negative
values) the ζ potential [18] and also increasing the PMP of yeast cells
[18,32]. Due to the general similar characteristics of the effects of
miconazole, experiments were performed to measure this parameter.
As shown in Fig. 8, this parameter changed to more negative values as
the pH increased. Low concentrations (20 μM) of the antifungal were
found to produce also an increase (to less negative values) of the ζ
potential. This parameter was found to be dependent on the pH of the
medium, being smaller as the pH was increased.
3.9. The effect of the antifungals on growth is reversible
It was decided to look at the effects of the antifungals on growth,
after incubating similarly to the experiment of Fig. 4, and spreading a
Fig. 9. Colony forming units (CFU) of cells incubated with variable concentrations of
ketoconazole (K) or miconazole (M). Cells were incubated as indicated under Material
and methods. A suitable dilution was spread with a known number of cells on YPD
plates to detect CFU after incubation for 48 h at 30 °C, n=3.
Fig. 7. Efﬂux of K+ produced by the addition of 100 μM ketoconazole (K) or miconazole
(M) to fasted yeast at different pH values, with (M+G or K+G) or without (K or M)
glucose as substrate. Results are expressed as the percentage of internal K+
concentration leaving the cells after incubation. The mean total concentration of K+
in the cells was 171 mM. n=4.
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regarding the possible reversibility of the effects observed after
10 min incubations. Fig. 9 shows that, under these conditions, the
number of CFU's was only slightly decreased by miconazole at
concentrations much higher than those producing the efﬂux of K+.
These results were similar with three different wild type strains,
FY833, W303-1A, and the commercial strain La Azteca.3.10. Effects of the antifungals on mutants deﬁcient in cation carriers
Experiments were also carried out in an attempt to deﬁne the
possible K+ carriers involved in the effects of the drugs. Particularly
important is the Tok1p, identiﬁed as an outward-rectifying channel
[33]; however, other known transporters were also explored: Nha1p
[34], Kha1p [35,36], and Nhx1p [37,38]. Although involved in the
uptake of monovalent cations [39,40], the mutant of Trk1p was also
studied.Fig. 8. Changes of the ζ potential produced by miconazole (M) in yeast cells. This
parameter was measured through the electrophoretic mobility of the cells in an electric
ﬁeld. From that, the ζ potential (mV) was calculated as described under Material and
methods.3.10.1. Potassium content of starved and non-starved cells
First, it was considered necessary to measure the internal content
of the different strains used, both with and without starvation for
18 h, after growing for 24 h (Table 3). In non-starved cells, the K+
content of the cells was not very different among the strains, except
for a tendency of the Δkha1–Δnha1 and Δnhx1mutants to a higher K+
accumulation, as compared to the parental strain FY833, and both the
W303-1A and its Δtok1 mutant (TOW), as well as the Azteca strain,
showed a lower accumulation of the cation. In fasted cells, the Δtrk1,
but not the Δtrk2 mutant, was found to contain a lower K+
concentration, as expected because it was starved in the absence of
the cation and due to its inability to reaccumulate it during starvation.
3.10.2. Effects of the azoles on K+ efﬂux in the mutants
The effects on the mutants were determined with 50 μM ke-
toconazole. In non-starved cells, results presented in Table 4, com-
paring each mutant with its corresponding parental strain can be
summarized as follows: Contrary to what was expected, in the non-
fasted Δkha1, but not in the Δnha1 mutant, more, not less, efﬂux was
observed. In addition, as expected, a much larger efﬂux was produced
in both Δtrk1 mutants, but not in the single Δtrk2 mutant, since the
former mutation results in the incapacity to reuptake the extruded
monovalent cation.
Experiments were also performed with starved cells, with 50 μM
ketoconazole (Table 5). Contrary to what was found in non-starved
cells, with these cells, a signiﬁcantly lower efﬂux of K+ was found to
be produced in the Δkha1 and Δnha1, and the double mutant, as well
as in the Δnhx1. As expected, a much higher efﬂux was also observed
in the Δtrk1 mutants, single or combined with the Δtrk2 deletion. In
contrast to what we expected, the Δtok1 mutant did not show any
difference as compared to its W303-1A parental strain.
3.10.3. Effects on the apparent PMP
As another indicator of the increased PMP produced by the drugs,
their effect on the actual uptake of the cyanine DiSC3(3) was
measured. The experiments were performed in the presence of
glucose to energize the cells. To avoid cyanine accumulation by the
mitochondria, 10 μM CCCP was added, as well as 10 μM BaCl2 to
prevent its binding to the surface of the cells. From the ratio of the
internal/external concentration of the cyanine and the Nernst
equation, a value for the PMP was calculated (see Material and
Table 3
Potassium content of the different wild type and their corresponding mutant strains
after growth, or after growth and fasting for 18 h.
Internal K+, mM; mean±S.D.
Non fasted Fasted
Azteca 248±14 171±18
FY833 276±4 181±13
Δkha1 265±22 180±7
Δnha1 273±21 179±18
Δkha1- Δnha1 295±20 183±1
Δnhx1 302±19 172±8
Δtrk1 273±11 157±9
Δtrk2 287±20 172±10
W303-1A 248±12 138±8
TOW (Δtok1) 249±13 137±3
After growth for 24 h, the cells were collected by centrifugation, washed, and either
used immediately or after aeration in water for 18 h. K+ was measured as indicated in
Materials and methods (n=5).
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accumulation of DiSC3(3), and of course, a higher value for the
calculated PMP; in order to simplify, only experiments with 50 μM
ketoconazole are presented. Results with the different mutants are
compared to those with the FY833 and W303-1A used as parental
strains of mutants of several transporters involved in the movements
of K+ (Table 6, non-fasted cells; Table 7, fasted cells). In all cases, even
in thosewith a low signiﬁcance (high p value), due to some dispersion
of the data, the addition of the drugwas found to produce a signiﬁcant
increase of the uptake of the cyanine, and, consequently, of the
calculated PMP; these cases are indicated in the tables by a double
asterisk.3.10.4. Inhibition of respiration by miconazole
Miconazole inhibits respiration of isolated mitochondria, report-
edly due to an oligomycin-like effect on the ATPase [6,7], similarly to
other organic, cationic, and amphipathic molecules capable of
entering the mitochondria and inhibiting respiration [41]. Results in
Fig. 10 show that miconazole produced an inhibition of respiration
only at concentrations of 150 μM or higher. Considering the effects
reported by Portillo and Gancedo [6,7], of an oligomycin-like effect of
miconazole, the effect of the uncoupler CCCP, which stimulated
respiration, was tested; once respiration was inhibited by the drugs,
no reversal of the inhibition was observed with the uncoupler.Table 4
Efﬂux of K+ produced by 50 μM ketoconazole in wild type and mutant strains of S.
cerevisiae. Non-fasted cells.
Strain Mean efﬂux, mM
(percent of control±S.D.)
n Signiﬁcance
(p)
FY 19.32 (7.0±2.3) 7
Δkha1 30.74 (11.6±4.5) 13 b0.01
Δnha1 60.95 (23.4±6.8) 9 b0.01
Δkha1- Δnha1 46.9 (15.9±8.5) 3 0.21
Δnhx1 60.1 (19.9±5.4) 8 b0.01
Δtrk1 168 (61.8±16.0) 3 0.026
Δtrk2 38.7 (13.5±4.0) 3 0.090
Δtrk1–Δtrk2 166.8 (61.8±8.2) 3 b0.01
W303-1A 43.6 (17.6±5.3) 3
TOW (Δtok1) 56.5 (22.7±1.5) 3 0.10
After growth for 24 h, the cells were collected by centrifugation, washed, and used
within few hours. Incubation was performed either in the presence or absence of 50 μM
ketoconazole. After incubation, the cells were centrifuged, and K+ was measured in the
supernatant by ﬂame photometry (n as indicated). The signiﬁcance level was
determined by the Student's t test (value of p). Results are expressed as the efﬂux of
K+ inmM concentration, followed in parenthesis by the percentage of the total content
of each strain±S.D.4. Discussion
4.1. The antifungals are taken up by diffusion and binding
The transport of both antifungals is shown to occur by free
diffusion, as indicated by the linearity of the uptake curves at different
concentrations; this mechanism may also explain why the uptake,
differently from other cationic organic molecules [29], did not depend
on the presence of glucose. S. cerevisiae was used because this yeast
has similar drug sensitivity and extrusion properties to C. albicans, a
common human pathogen [15]. Our results with ketoconazole
conﬁrm the uptake mechanism reported for C. albicans [16]. It is
worthwhile mentioning that at all concentrations the uptake of
ketoconazole and miconazole was around 75% and 90%, respectively,
showing a large concentration of both drugs by the cells. Moreover,
although these experiments were carried out after 10 min at 30 °C
incubation, similar ones (not shown) were performed in which the
uptake was studied immediately after adding the antifungals, at room
temperature or in ice water, and the uptake was similar, implying a
physical diffusion phenomenon because of the amphipathic and
cationic nature of the molecules, with a further binding to the internal
hydrophobic structures of the cell. Binding occurred also at the surface
of the cells, as shown by the changes in the ζ potential (Fig. 8). These
data are important, since no reports exist about the mechanism of
uptake of these drugs in S. cerevisiae [15], and the ﬁnding of the actual
concentration inside the cells should be considered regarding their
concentration–effect ratio. Besides, the effects of these antifungals
could be observed at concentrations lower than those attained in
humans upon the therapeutic administration of the drugs. Ketocona-
zole has been reported to reach values of 50 μg/mL of serum, i.e.,
around 100 μM [42]. Interestingly, it has been found recently that lipid
rafts are involved in the entrance of miconazole [43]. The usually
larger effects with miconazole described later may be a consequence
of its higher uptake, as compared to ketoconazole.
4.2. The antifungals produce an efﬂux of K+
Although the primary mode of action of ketoconazole and
miconazole involves the inhibition of sterol synthesis through its
action on P450 cytochromes [1–4], our results extend the ﬁndings
regarding their effects on cation transport systems [9–12]. Ketocona-
zole and miconazole produced an efﬂux of K+ at low concentrations
and, at around 200 μM, they produced almost depletion of the cation
from the cells. At low concentrations, this effect depended on the
presence of glucose, as it has been found for other agents that produce
K+ efﬂux in yeast, such as streptomycin [44], ethidium bromide [45],
and Tb3+ [46]. This partial dependency on glucose as an energy source
for the effect, and not of the uptake, may imply that the K+ efﬂux
system is activated by some intermediary of metabolism or the energy
state of the cell. Miconazole is somewhat different in this respect,
since its glucose requirement to produce the efﬂux of K+ and other
changes was less marked. It is possible that both antifungals produce
the K+ efﬂux by acting on different transporters, or that their effect is
similar, but inﬂuenced by their structure, aside from the imidazolic
moiety, which seems to be the active portion. The lower effect of
ketoconazole in the K+ efﬂux may be explained because of its
structure, and it appears to be less hydrophobic, due to the presence of
polar groups in its non-polar tail. Otherwise, their pK's are similar, and
the pH dependency of the effects observed do not appear to be due to
protonation differences of the molecules, as previously found by
Beggs [47]. It is also worth mentioning that the effects of these drugs
are fungistatic, at least regarding lethality under our conditions, as
shown by the fact that, after the incubation, the number of CFU's did
not show a large decrease. After incubation with the drugs, the cells
recovered their viability when spread on YPD in their absence. It has
to be stressed that the K+ efﬂux produced by the fungistatics is
Table 5
Efﬂux of K+ produced by 50 μM ketoconazole in wild type and mutant strains of S.
cerevisiae. Fasted cells.
Strain Mean efﬂux, mM
(percent of control±s. d.)
n Signiﬁcance
(p)
FY 35.2 (19.5±3.9) 6
Δkha1 11.9 (6.6±3.3) 16 ≪0.01
Δnha1 15.2 (8.5±5.0) 9 ≪0.01
Δkha1–Δnha1 21.4 (11.7±3.6) 3 ≪0.01
Δnhx1 21.1 (12.3±3.3) 9 ≪0.01
Δtrk1 103.3 (65.8±2.9) 2 ≪0.01
Δtrk2 30.7 (17.9±6.8) 2 0.80
Δtrk1–Δtrk2 118.1 (69.5±5.9) 2 0.03
W303-1A 38.2 (27.7±14.5) 3
TOW (Δtok1) 30.0 (21.9±10.0) 3 0.60
After growth for 24 h, the cells were collected by centrifugation, washed, and used after
aeration in water for 18 h (see Materials and methods). Incubation was performed
either in the presence or absence of 50 μM ketoconazole. After incubation, the cells
were centrifuged, and K+ was measured in the supernatant by ﬂame photometry (n as
indicated). The signiﬁcance level was determined by the Student's t test (value of p).
Results are expressed as the efﬂux of K+ in mM concentration, followed in parenthesis
by the percentage of the total content of each strain±S.D.
Table 7
Effects of 50 μM ketoconazole on the PMP of the Saccharomyces cerevisiae strains and
mutants of different K+ carriers. Fasted cells.
Strain Calculated PMP, mV p, vs.
FY
p, vs.
control⁎
Mean±S.D.
FY −181.4±8.0
FY K 50⁎ −194.1±10.4 0.106
Δkha1⁎ −199.1±11.5 0.130
Δkha1 K 50 −203.6±7.8 0.290
Δnha1 −183.2±7.6 0.764
Δnha1 K 50 −198.3±6.3 0.023
Δkha1–Δnha1 −184.3±7.8 0.626
Δkha1–Δnha1 K 50 −197.7±4.2 0.033
Δnhx1 −183.8±7.1 0.667
Δnhx1 K 50 −195.2±6.0 0.051
Δtrk1⁎ −199.6±8.8 0.023
Δtrk1 K 50 −208.7±7.5 0.165
Δtrk2 −186.3±8.7 0.890
Δtrk2 K 50 −197.5±8.8 0.099
Δtrk1–Δtrk2⁎ −203.2±8.3 0.075
Δtrk1–Δtrk2 K 50 −207.3±9.4 0.277
W303-1A −194.2±6.9 0.053
W303-1A K 50 −201.0±5.6 0.175
TOW (Δtok1) −192.3±6.5 0.705
TOW (Δtok1) K 50 −205.3±2.6 0.021
The experiment was performed as for Table 4, but cells grown for 24 h and then starved
for 16 h were used.
⁎ Experiments in which although signiﬁcance was not observed by the p value, in all
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results obtained with the Δtrk1 mutants; in which, being unable to
transport it inside, the efﬂux was found remarkably higher than in
other strains or mutants.of them, a higher value for the PMP was observed, as compared to the reference strain.
K 50, in the presence of 50 μM of ketoconazole. n=4.4.3. The antifungals do not produce disruption of the cells, but the
secondary efﬂux of anions and the inﬂux of H+
It appeared possible that the effectswere due to the disruption of the
cells, as indicated by the efﬂux of material absorbing at 260 nm and of
phosphate in the supernatant obtained after incubating the cells with
thedrugs and centrifuging.However, although thesematerials appear inTable 6
Effects of 50 μM ketoconazole on the PMP of the Saccharomyces cerevisiae strains and
mutants of different K+ carriers. Non-fasted cells.
Calculated PMP, mV p, vs.
FY
p, vs.
control⁎
Means±S.D.
FY −173.6±4.9
FY K 50 −197.7±9.1 0.004
Δkha1⁎ −184.8±5.9 0.068
Δkha1 K 50 −199.9±8.6 0.028
Δnha1 −180.6±3.4 0.123
Δnha1 K 50 −196.8±6.6 0.008
Δkha1–Δnha1 −170.3±4.0 0.031
Δkha1–Δnha1 K 50 −194.0±4.1 0.002
Δnhx1 −172.2±1.5 0.672
Δnhx1 K 50 −190.7±2.7 0.002
Δtrk1⁎ −183.7±4.4 0.051
Δtrk1 K 50 −208.3±9.7 0.035
Δtrk2 −166.0±10.5 0.341
Δtrk2 K 50 −188.8±10.1 0.054
Δtrk1–Δtrk2⁎ −194.5±4.9 0.057
Δtrk1–Δtrk2 K 50 −211.8±7.7 0.236
W303-1A −176.6±5.8 0.528
W303-1A K 50 −184.0±4.2 0.144
TOW (Δtok1) −178.3±6.5 0.030
TOW (Δtok1) K 50 −185.5±6.1 0.211
Non-starved cells (50 mg, wet weight) were incubated as indicated under Materials
and methods. The supernatant, after the addition of 1.0% sodium dodecyl sulfate, was
measured by its ﬂuorescence at 540-590 nm. From the amount in the supernatant and
the total added, the internal concentration of the cyanine was obtained. Using the
Nernst equation, the PMP was calculated. K 50, in the presence of 50 μM of
ketoconazole. Values are given as the means of 6 or 7 experiments±S.D.
⁎ Experiments in which although signiﬁcance was not observed by the p value, in all
of them, a higher value for the PMP was observed, as compared to the reference strain
(control).the supernatant, their proportion of the total content of the cells,
compared to K+ efﬂux, was smaller. Nucleotides, which are the main
material absorbing at 260 nm, as well as phosphate, are of anionic
nature, andmay, at least partly, be accompanying potassium in its efﬂux
from the cell through anionic transporters. It is understandable that the
efﬂux of phosphate was larger than that of nucleotides, because the
former is the most abundant anion of the cells, apparently forced to
accompany K+. The efﬂux of K+ produced by Tb3+ is accompanied by
theefﬂuxofphosphate [37]. It is also interesting that even in theabsence
of the antifungals, a small efﬂux of material absorbing at 260 nm was
observed that depended on the presence of glucose. This ﬁnding is not
surprising: ketoacids [48] and succinate [49] have been found to be
extruded from yeast cells. Moreover, the internal/externalFig. 10. Oxygen consumption by yeast cells and the effects of miconazole and CCCP.
Numbers next to the tracings indicate the micromolar concentrations of miconazole
already present during the experiment. Where indicated, 10 μM of CCCP was added.
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[50,51]. In addition, the dependence on glucose of the nucleotide efﬂux
in the absence of the antifungals may indicate that the efﬂux is not due
to the disruption of the cells, but to another mechanism, or due to other
anions. Against the simple disruption of the cell membrane are the
following facts: a) the changes of the internal pHof the cells couldnot be
expected to recover by the addition of K+ after the drugs; b) in the
presence of the antifungals, the PMP was not only not decreased, but
rather increased: c) no activity of glucose-6-phosphate dehydrogenase
was detected in the presence of the antifungals; d) it was found that
both antifungals did not produce any changes in the uptake of 86Rb+.
Besides the K+ efﬂux, the measurement of proton pumping by the
cells into the incubation medium showed that immediately after their
addition, and starting at around 40 μM, both antifungals produced a
pH increase of the medium, indicating an inﬂux of protons, partly
compensated by the proton pumping by the plasma membrane H+-
ATPase. This proton inﬂux was absent at the lower concentrations,
much smaller than the efﬂux of K+, and larger at the intermediate or
higher concentrations tested. At the highest concentrations of the
drugs, the efﬂux of K+ was close to 20 μEq, while the maximum inﬂux
of protons with miconazole was around one-hundredth (0.2 μEq).
This means that the efﬂux of K+ is the primary effect, and only at the
higher drug concentrations, at a much lower proportion, an inﬂux of
protons is produced. Both drugs may be activating a K+/H+ exchange
system in the cell. These antiporters have been found widely
distributed among living cells [52,53], and, in yeast, three of them
have been studied: Nha1p [34], Kha1p [35,36], and Nhx1p [37,38].
This K+ efﬂux was more marked in the presence of glucose, and is
partly balanced by an uptake, as derived from the fact that, even after
the signiﬁcant internal acidiﬁcation of the cells observed at the higher
concentrations of the drugs, the addition of K+ produced a rapid
alkalinization of the cell interior, followed by another slower but
appreciable alkalinization rate (Fig. 5). This assumption is also
reinforced by the fact that the efﬂux was much higher in the Δtrk1
mutants, lacking the main K+ inﬂux transporter.
Indicating also the possible role of a K+/H+ exchanger are the
results of K+ efﬂux (Fig. 7), which increased with miconazole as the
external pH was lowered. This is also supported by the lower effect of
ketoconazole on mutants of all three antiporters. It is however
difﬁcult to explain a) whywas this difference only observed in starved
cells, and b) why was this efﬂux less sensitive to the external pH with
ketoconazole; the behavior of this compound appears to be more
complex. Differences were also observed in the rate of internal
acidiﬁcation, which was slower with ketoconazole, as well as in
effectiveness, glucose dependence, and effects on the membrane
potential. To this respect, the degree of protonation of the drugs could
also be involved, as proposed by Beggs [47].
4.4. A net K+ outward system
Our ﬁndings show that the drugs produce a large net efﬂux of the
cation in which there is a role of K+/H+ exchangers; their main and
probably primary effect is to stimulate a net K+ efﬂux system. The ﬁrst
possibility would be a channel, such as those described in yeast [33],
resulting in the hyperpolarization of the cells as shown by the
increased ﬂuorescence and uptake of DiSC3(3), as well as the
increased uptake of 45Ca2+ (not shown), also found by Eilam et al.
[8]. The efﬂux of K+ through such a system would be partially
modulated by the energy status of the cell, as indicated by the partial
requirement of glucose to produce the efﬂux of K+, and that when the
substrate was omitted smaller changes in the ﬂuorescence of the
cyanine, indicating a lower increase of the PMP, were observed with
ketoconazole (Fig. 6B), whereas with miconazole, which showed a
less strict glucose requirement to produce the efﬂux of K+, a higher
increase of the ﬂuorescence signal was detected also in the absence of
glucose (Fig. 6D). In the control cells, the addition of K+ produced aclear decrease of the PMP, but this decrement was slower in the
presence of the drugs. Together with the reduced rate of K+ uptake
after the efﬂux (Fig. 2), this might be an indication that both
ketoconazole and miconazole are also inhibitors of the uptake of the
cation; however, the measurement of the uptake of 86Rb+ failed to
show an inhibition at concentrations of up to 40 μMof the antifungals.
It has been reported [8] that miconazole produces K+ efﬂux from the
cells, part of which is concentrated in the vacuole, but in contrast to
our results, the authors found a decreased PMP. However, their
method tomeasure themembrane potential implied the incubation of
the cells with the membrane potential indicator for 90 min, which
may be a method less reliable to measure the changes right after the
addition of the drug, particularly because of the profound changes on
the ionic composition produced by these drugs. With both methods
used by us, a clear increase of the PMP, most probably resulting from
the efﬂux of K+, was observed.
4.5. Mechanism proposed
Taken together, the results could be visualized as follows, as
already proposed for amiodarone [18] and supported by similar
ﬁndings ofMaresova et al. [32]: the drugs appear to bind to the surface
of the cell by virtue of both their amphipathic and cationic nature, and
by decreasing (turning less negative) the surface charge of the
membrane, and decreasing the actual concentration of K+ available
for its transport into the cell, according to a given PMP; if this
concentration decreases, an efﬂux of the cation is possible. Another
possibility is that by the same change of the surface charge, the
membrane structure becomes disrupted by the interaction of the
antifungals with lipid rafts [43] and may contribute to this effect or to
the functioning of the cation transporters. As a consequence, both
antifungals at low concentrations can stimulate the efﬂux of K+, but
ketoconazole in a partially energy-dependent way. At higher
concentrations, the higher PMP generated at the level of the plasma
membrane can stimulate or drive the uptake of H+, which might
imply the participation of a K+/H+ exchanger. The increased negative
PMP could also drive the efﬂux of anions out of the cell, as well as the
inﬂux of H+. Results indicate that after producing the K+ efﬂux,
particularly at the lower or intermediate concentrations of the
antifungals, the cells appear to maintain a cycling of K+, in which a
balance towards the efﬂux is established against an unaltered inﬂux
through the K+ uptake systems.
Probably, themain ﬁnding from the experiments with themutants
is that the mutation of Tok1p eliminated the most plausible candidate
for a straightforward mechanism; its absence did not result in any
difference in the effect of the azoles as compared to the wild type
strain; differenceswere found in neither the K+ efﬂux nor the changes
produced by the drugs on the PMP. However, although different
results were obtained in the non-starved and starved cells, regarding
the mutation of the Kha1p and Nha1p, in the starved cells, results
indicate the participation of theseH+/K+ exchangers. From these data,
it appears probable that ketoconazole and miconazole may affect the
function of these transporters, but since they do not alter the uptake of
K+, as demonstrated by the 86Rb+ uptake experiments, a large part of
the effects of the drugsmay be compensated by the combined action of
theH+-ATPase and the inﬂux of themonovalent cation through Trk1p.
Thismay be supported by the fact that in themutants of Trk1p,without
the main uptake system for monovalent cations, the efﬂux produced
by both imidazolic compounds was remarkably larger.
4.6. The effects on respiration
Respirationwas affected bymiconazole and ketoconazole, but only
at concentrations above 150 μM. This is probably related to the
cationic nature of the imidazolic portion of the molecule. Amidine
groups, originally found to interact with sodium channels [54], and
444 M. Calahorra et al. / Biochimica et Biophysica Acta 1808 (2011) 433–445other compounds, particularly octylguanidine, were found to inhibit
mitochondrial respiration [55]. A similar effect was described for
ethidium bromide in mitochondria [41]. This inhibition also means
that these antifungals can reach this organelle, although its mecha-
nismwould require further studies with isolated mitochondria. In our
experiments, the inhibition of respiration was not reversed by CCCP,
neither with ketoconazole nor withmiconazole, as would be expected
from the data of Portillo and Gancedo [6,7]. In any case, the effects on
respiration in intact cells were observed only at high concentrations of
the antifungals.
4.7. Final remarks
It is important to point out that the efﬂux of K+ could be observed
with ketoconazole and miconazole, similar antifungals, in agreement
with other authors [14], but not with two triazolic antifungals,
ﬂuconazole and itraconazole, which may indicate that the active
group of the molecule in the interaction with the carriers is the
imidazole moiety of the molecule.
Our incapability to fully explain the results may be due to our still
incomplete knowledge of the ﬁne mechanisms and possible interac-
tions of the different transporters involved in the homeostasis of
monovalent cations in yeast.
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